In brief
- A team at Northeastern University (USA) has published the first functional neuroimaging study on mescaline, conducted in awake rats.
- The cerebellum “shuts down” locally but increases its connections with other regions—a pattern not observed with LSD or psilocybin.
- The ability to filter auditory stimuli is selectively altered based on frequency, in a pattern reminiscent of that described in the early stages of schizophrenia.
Researchers at the Center for Translational Neuroimaging at Northeastern University, in Boston, have published the first functional magnetic resonance imaging (fMRI) mapping of mescaline’s effects on a living, awake brain in the journal Neuroscience Bulletin. The key finding: this molecule, traditionally extracted from peyote and cacti such as San Pedro, acts on the cerebellum in a way that does not match other classic psychedelics previously studied using the same technique.
A classic psychedelic rarely examined with MRI
Mescaline is, along with the peyote that contains it, one of the psychoactive substances with the longest documented ceremonial history, with thousands of years of recorded use in communities in northern Mexico and the southwestern United States. Despite this history, its classification as a controlled substance has left its neurobiology much less explored than that of LSD or psilocybin. The team led by doctoral candidate Noah Cavallaro and Professor Craig Ferris sought to bridge part of this gap using fMRI in conscious rats, a technique that allows for the observation of brain activity in real time without the need for anesthesia. As Psiconáutica’s own guide on harm reduction notes, the better a substance’s mechanism is understood, the better one can be informed about its actual effects, beyond myths or alarmism.
A cerebellum that powers down while “talking” more to the rest of the brain
After administering mescaline, the animals showed a selective suppression of the BOLD signal (the indicator used by fMRI to measure activity) in the cerebellum, as if this region were partially disconnecting from the rest of the forebrain. However, when analyzing resting-state connectivity, the researchers observed the opposite effect: the cerebellum began communicating more intensely with the hippocampus, thalamus, somatosensory cortex, and midbrain—a pattern of global hyperconnectivity that the authors describe as “paradoxical.” In prepulse inhibition tests, which measure the ability to filter sounds, animals under the influence of mescaline showed improved filtering at 4 kHz (+27.6%) and 20 kHz (+27.3%) tones, but a deterioration at 12 kHz (-16.4%); they also stopped responding to odors they normally find attractive. The authors note that this hyperconnectivity pattern resembles that described in people with schizophrenia during their first episode, though they emphasize that this is a similarity in connectivity, not a clinical equivalence. Those who wish to delve deeper into how this substance fits into the family of classic psychedelics can consult the Psiconáutica psychedelics hub.
What this implies
This is a preclinical study in rodents, not humans, and the authors themselves highlight this: a rat cannot describe what it perceives, so the translation to the subjective human experience is limited. What it does provide is an initial objective neurobiological footprint showing that mescaline does not behave like a simple “milder LSD,” but rather has its own signature regarding the cerebellum and sensory integration—something the researchers plan to continue working on through dose-response studies and, eventually, human research. At a time when regulatory and clinical interest in classic psychedelics is growing, understanding what distinguishes each molecule—rather than treating them as a homogeneous block—is a relevant step for both basic science and any future responsible therapeutic use.
Source
- Northeastern University. “Mescaline Drug Effects: What It Does to the Brain” (study by Cavallaro, N., Ferris, C. et al., “Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats”, Neuroscience Bulletin). News @ Northeastern, July 20, 2026.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
